Skip to main content
. 2020 Oct 15;2020:5847429. doi: 10.1155/2020/5847429

Figure 2.

Figure 2

The utilization of chemotherapy in different cancer types between two groups. MRONJ patients with administration of chemotherapeutic agents in group A and group B were 11 and 21, respectively. The proportion of every cancer type (%) was the number of different cancer types of patients receiving chemotherapy divided by the total number of MRONJ patients receiving chemotherapy